Target intelligence / Profile preview

Ebola virus glycoprotein (GP)

Target: GP
Molecular classification: Viral protein, Glycoprotein, Membrane fusion protein

Overview

The Ebola virus glycoprotein (GP) is the sole viral protein expressed on the surface of the virion and is essential for mediating attachment to host cells, entry via endocytosis, and subsequent membrane fusion. It is a primary target for antiviral drug development, vaccines, and neutralizing antibodies due to its critical role in viral infectivity.

Other names: EBOV-GPFull-length GPSoluble GP (sGP)Small soluble GP (ssGP)

Mechanism of action

Attachment to host cells, entry via endocytosis, and subsequent membrane fusion.

Biological functions

Viral attachmentViral entryMembrane fusionImmune evasion

Disease associations

Infection

Safety considerations

Immune evasion due to extensive glycosylationShielded epitopes hindering neutralizing antibody response

Beyond the preview

Go deeper on Ebola virus glycoprotein (GP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ebola virus glycoprotein (GP).

Explore the full profile